TABLE 5.
Summary measures to quantitatively describe the distribution of values analyzed in Table 4
| Virus | Status | n | % CD4 CD8 DP thymocytes
|
CD4 SP/CD8 SP thymocyte ratio
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SEM | Median | Minimum | Maximum | Q(0.25) | Q(0.75) | Mean | SEM | Median | Minimum | Maximum | Q(0.25) | Q(0.75) | |||
| Mock | Nonpathogenic | 27 | 77.6 | 1.3 | 79.0 | 64.0 | 88.0 | 72.5 | 82.5 | 2.5 | 0.1 | 2.3 | 1.6 | 3.8 | 2.0 | 3.2 |
| 8G9 | Unknown | 5 | 78.8 | 2.3 | 78.0 | 74.0 | 85.0 | 74.0 | 83.0 | 2.2 | 0.2 | 2.3 | 1.5 | 2.6 | 2.0 | 2.4 |
| 32D2 | Unknown | 5 | 77.2 | 4.9 | 80.0 | 60.0 | 89.0 | 75.0 | 82.0 | 2.2 | 0.2 | 2.0 | 1.6 | 2.8 | 2.0 | 2.4 |
| E11 (CCR5 +/+ grafts) | Unknown | 7 | 55.7 | 8.1 | 63.0 | 23.0 | 77.0 | 43.5 | 70.0 | 1.3 | 0.3 | 1.1 | 0.4 | 2.7 | 1.0 | 1.4 |
| E11 (CCR5 +/Δ32) | Unknown | 4 | 85.0 | 1.5 | 85.5 | 81.0 | 88.0 | 84.0 | 86.5 | 1.9 | 0.1 | 1.9 | 1.6 | 2.0 | 1.8 | 2.0 |
| NL4-3 | Pathogenic | 30 | 6.1 | 1.3 | 3.0 | 0.0 | 21.0 | 1.0 | 8.0 | 0.3 | 0.1 | 0.2 | 0.0 | 1.2 | 0.1 | 0.4 |